None
Conditions
Interventions
None listed
Sponsors
FANCL Corporation
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1)Women aged 20-69 years at the time of consent 2)Individuals who can attend the study site on the scheduled examination dates and undergo the required tests 3)Individuals deemed eligible for participation in this study by the investigator
Exclusion criteria
Exclusion criteria: 1)Individuals with skin conditions (e.g., atopic dermatitis) receiving outpatient care or medication. 2)Individuals with implanted electronic medical devices. 3)Individuals who initiated or changed medication for chronic diseases within the past three months. 4)Individuals with current or past alcohol or drug dependence. 5)Individuals with soy allergies. 6)Individuals who underwent facial cosmetic procedures within the past six months or plan such procedures during the study. 7)Individuals who used physician-prescribed medications for dermatological or cosmetic purposes within the past six months. 8)Individuals who received facial treatments at beauty salons or aesthetic clinics within the past four weeks before the study or plan to do so during the study. 9)Individuals exposed to excessive UV radiation (e.g., outdoor activities) within the past four weeks or unable to avoid intentional sun exposure (e.g., tanning) during the study. 10)Individuals vaccinated within the past four weeks or planning vaccination during the study. 11)Individuals who used probiotics, antibiotics, or antimicrobials affecting gut microbiota within the past three weeks or plan to use them during the study. 12)Individuals who traveled abroad within the past two weeks or plan to travel during the study. 13)Individuals likely to require anti-allergy medications due to seasonal allergies (e.g., hay fever) during the study. 14)Individuals currently pregnant, breastfeeding, or planning pregnancy during the study. 15)Individuals who donated blood within the past four weeks or plan to donate during the study. 16)Individuals participating or recently participated (within four weeks) in another clinical study. 17)Individuals deemed unsuitable by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Objective Skin Function-related Assessments Subjective Skin Function-related Assessments | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood, Urine and Fecal Tests Physical Examinations Lifestyle Surveys Subjective Symptoms | — |
Countries
Japan
Contacts
Public ContactRyoma Shimizu
TES Holdings Co., Ltd. Administrative Department of Clinical Trials
Outcome results
None listed